Mohamed Elkhateeb

• Exceeded annual sales targets through strategic planning, territory optimization, and customer relationship building.
• Managed change effectively during organizational restructuring or product launches, minimizing disruption on the team''s performance.
• Optimized resources allocation to maximize sales results within the assigned budget constraints.
• Held one-on-one meetings with sales team members to identify selling hurdles and offered insight into best remedy.
• Built relationships with customers and community to establish long-term business growth.

Leading team (8 members) to achieve sales objectives ensure alignment and execution of SBCP, market feedback and insights, sustainable portfolio growth verse market new product launch.

Consistent achievement for classical products and new launches for allergy and Pedia portfolio with over 100% achievement. Through F2F and remote customer engagement building long term business relation with key HCP's (Pedia ,Ent ,Derma ,Gp ,IM)

• Achieved sales target per brand per Quarter.
• Achieved Market Share objective.
• Achieved 126% of total year Target 2021/achieved Telfast family market leadership.
• Best achiever Nasacort total year 2020 with the highest growth and market share 50% M.s.
• On boarding Training (product knowledge, role plays) for newly joined medical reps 2019-2021
• Conducted several chain pharmacies standalone presentations 50+ attendees, for strategic Otc products and soft skills (El-Ezzaby, Image , Ezz -Eldin , Misr) 2017-2019
• Key account management (Egypt-Air) Market leader antihistamine (Telfast) and was able to list Nasacort in the tender for the first time. 2014-Present.

Achieved target sales figures for respiratory portfolio, anti-infective, worked with (Chest,Ent,Ortho,Pedia,Derma,GP,IM) specialties in different territories:
(Downtown, Shubra, Dokki, Heliopolis,Nasrcity,NewCairo)
•
Best achiever respiratory line 2009 with 135% total year with all products above 100% achievement
•
Key account management (Police Hospital) highest growth for Claforan and Tarivid 2009-2013
•
KOL Management: managing key innovator HCP in:
•
Chest (Prof.Adel Khattab,Tarek Safwat, Maysa Sharaf Eldin)
•
Ent (Prof. Badr eldin Mostafa, Osama abdel nussier, Osama abdel hamid)
•
Derma (Prof: Mostafa abo zied, Assem farag , Mohsen Soliman, Mahmoud abdel rehim Abdallah , Mahira Hamdy)
•
Pedia(Prof.Hamed el Khayat, Prof Adel Ryad, Prof Thrwat Deraz, Prof Ehab Khairy)